Early Diagnosis and Its Impact on PFIC2 Treatment Timely diagnosis of PFIC2 significantly influences treatment outcomes. Genetic testing confirms the presence of ABCB11 mutations, enabling early intervention. Initiating therapy during infancy can reduce symptom severity and delay liver damage. Regular liver function tests and imaging help track disease progression. Early detection empowers families and healthcare providers to make informed treatment decisions. Ref - https://www.marketresearchfuture.com/reports/progressive-familial-intrahepatic-cholestasis-type-2-treatment-market-27160